The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2019

Filed:

Jul. 17, 2018
Applicant:

National Tsing Hua University, Hsinchu, TW;

Inventors:

Suh-Chin Wu, Hsinchu, TW;

Shao-Ping Yang, Hsinchu, TW;

Hsiao-Han Lin, Hsinchu, TW;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/10 (2006.01); A61K 39/12 (2006.01); C07K 14/18 (2006.01); A61K 47/68 (2017.01); A61P 31/14 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1081 (2013.01); A61K 39/12 (2013.01); A61K 47/6839 (2017.08); A61P 31/14 (2018.01); C07K 14/1825 (2013.01); A61K 2039/53 (2013.01); C12N 7/00 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24134 (2013.01);
Abstract

Provided herein are a mutant envelope protein of Zika virus and a nucleic acid molecule including a nucleotide sequence encoding the mutant envelope protein. The mutant envelope protein, which preferably has a threonine substitution at 105position, or an asparagine substitution at 248position and a threonine substitution at 250position in an amino acid sequence of SEQ ID NO: 1, includes an N-glycan masking a fusion loop region of the mutant envelope protein of Zika virus. Also provided herein is a vaccine composition, including the mutant envelope protein or a recombinant virus including the nucleic acid molecule. Also provided herein is a method of preventing Zika virus infection and reducing antibody-dependent enhancement of dengue virus infection, including administering to a subject in need thereof an effective amount of a vaccine composition including the mutant envelope protein of Zika virus.


Find Patent Forward Citations

Loading…